Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice

Jon T. Willie, Hitomi Takahira, Megumi Shibahara, Junko Hara, Mika Nomiyama, Masashi Yanagisawa, Takeshi Sakurai

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Orexins (also called hypocretins), which are neuropeptides exclusively expressed by a population of neurons specifically localized in the lateral hypothalamic area, are critically implicated in the regulation of sleep/wake states. Orexin deficiency results in narcoleptic phenotype in rodents, dogs, and humans, suggesting that orexins are important for maintaining consolidated wakefulness states. However, the physiological effect of constitutive increased orexinergic transmission tone, which might be important for understanding the effects of orexin agonists that are promising candidates for therapeutic agents of narcolepsy, has not been fully characterized. We report here the sleep/wakefulness abnormalities in transgenic mice that exhibit widespread overexpression of a rat prepro-orexin transgene driven by a β-actin/ cytomegalovirus hybrid promoter (CAG/orexin transgenic mice). CAG/orexin mice exhibit sleep abnormalities with fragmentation of non-rapid eye movement (REM) sleep episode and a reduction in REM sleep. Non-REM sleep was frequently disturbed by short episodes of wakefulness. EEG/EMG studies also reveal incomplete REM sleep atonia with abnormal myoclonic activity during this sleep stage. These results suggest that endogenous orexinergic activity should be appropriately regulated for normal maintenance of sleep states. Orexinergic transmission should be activated during wakefulness, while it should be inactivated or decreased during sleep state to maintain appropriate vigilance states.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalJournal of Molecular Neuroscience
Volume43
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Wakefulness
REM Sleep
Sleep
Muscles
Eye Movements
Transgenic Mice
Lateral Hypothalamic Area
Narcolepsy
Sleep Stages
Neuropeptides
Cytomegalovirus
Transgenes
Actins
Electroencephalography
Rodentia
Maintenance
Dogs
Phenotype
Neurons

Keywords

  • Hypocretin
  • Orexin
  • Overexpression
  • Sleep
  • Transgenic
  • Wakefulness

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice. / Willie, Jon T.; Takahira, Hitomi; Shibahara, Megumi; Hara, Junko; Nomiyama, Mika; Yanagisawa, Masashi; Sakurai, Takeshi.

In: Journal of Molecular Neuroscience, Vol. 43, No. 2, 02.2011, p. 155-161.

Research output: Contribution to journalArticle

Willie, Jon T. ; Takahira, Hitomi ; Shibahara, Megumi ; Hara, Junko ; Nomiyama, Mika ; Yanagisawa, Masashi ; Sakurai, Takeshi. / Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice. In: Journal of Molecular Neuroscience. 2011 ; Vol. 43, No. 2. pp. 155-161.
@article{06809576f37f44feb8061a7d8f41218a,
title = "Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice",
abstract = "Orexins (also called hypocretins), which are neuropeptides exclusively expressed by a population of neurons specifically localized in the lateral hypothalamic area, are critically implicated in the regulation of sleep/wake states. Orexin deficiency results in narcoleptic phenotype in rodents, dogs, and humans, suggesting that orexins are important for maintaining consolidated wakefulness states. However, the physiological effect of constitutive increased orexinergic transmission tone, which might be important for understanding the effects of orexin agonists that are promising candidates for therapeutic agents of narcolepsy, has not been fully characterized. We report here the sleep/wakefulness abnormalities in transgenic mice that exhibit widespread overexpression of a rat prepro-orexin transgene driven by a β-actin/ cytomegalovirus hybrid promoter (CAG/orexin transgenic mice). CAG/orexin mice exhibit sleep abnormalities with fragmentation of non-rapid eye movement (REM) sleep episode and a reduction in REM sleep. Non-REM sleep was frequently disturbed by short episodes of wakefulness. EEG/EMG studies also reveal incomplete REM sleep atonia with abnormal myoclonic activity during this sleep stage. These results suggest that endogenous orexinergic activity should be appropriately regulated for normal maintenance of sleep states. Orexinergic transmission should be activated during wakefulness, while it should be inactivated or decreased during sleep state to maintain appropriate vigilance states.",
keywords = "Hypocretin, Orexin, Overexpression, Sleep, Transgenic, Wakefulness",
author = "Willie, {Jon T.} and Hitomi Takahira and Megumi Shibahara and Junko Hara and Mika Nomiyama and Masashi Yanagisawa and Takeshi Sakurai",
year = "2011",
month = "2",
doi = "10.1007/s12031-010-9437-7",
language = "English (US)",
volume = "43",
pages = "155--161",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice

AU - Willie, Jon T.

AU - Takahira, Hitomi

AU - Shibahara, Megumi

AU - Hara, Junko

AU - Nomiyama, Mika

AU - Yanagisawa, Masashi

AU - Sakurai, Takeshi

PY - 2011/2

Y1 - 2011/2

N2 - Orexins (also called hypocretins), which are neuropeptides exclusively expressed by a population of neurons specifically localized in the lateral hypothalamic area, are critically implicated in the regulation of sleep/wake states. Orexin deficiency results in narcoleptic phenotype in rodents, dogs, and humans, suggesting that orexins are important for maintaining consolidated wakefulness states. However, the physiological effect of constitutive increased orexinergic transmission tone, which might be important for understanding the effects of orexin agonists that are promising candidates for therapeutic agents of narcolepsy, has not been fully characterized. We report here the sleep/wakefulness abnormalities in transgenic mice that exhibit widespread overexpression of a rat prepro-orexin transgene driven by a β-actin/ cytomegalovirus hybrid promoter (CAG/orexin transgenic mice). CAG/orexin mice exhibit sleep abnormalities with fragmentation of non-rapid eye movement (REM) sleep episode and a reduction in REM sleep. Non-REM sleep was frequently disturbed by short episodes of wakefulness. EEG/EMG studies also reveal incomplete REM sleep atonia with abnormal myoclonic activity during this sleep stage. These results suggest that endogenous orexinergic activity should be appropriately regulated for normal maintenance of sleep states. Orexinergic transmission should be activated during wakefulness, while it should be inactivated or decreased during sleep state to maintain appropriate vigilance states.

AB - Orexins (also called hypocretins), which are neuropeptides exclusively expressed by a population of neurons specifically localized in the lateral hypothalamic area, are critically implicated in the regulation of sleep/wake states. Orexin deficiency results in narcoleptic phenotype in rodents, dogs, and humans, suggesting that orexins are important for maintaining consolidated wakefulness states. However, the physiological effect of constitutive increased orexinergic transmission tone, which might be important for understanding the effects of orexin agonists that are promising candidates for therapeutic agents of narcolepsy, has not been fully characterized. We report here the sleep/wakefulness abnormalities in transgenic mice that exhibit widespread overexpression of a rat prepro-orexin transgene driven by a β-actin/ cytomegalovirus hybrid promoter (CAG/orexin transgenic mice). CAG/orexin mice exhibit sleep abnormalities with fragmentation of non-rapid eye movement (REM) sleep episode and a reduction in REM sleep. Non-REM sleep was frequently disturbed by short episodes of wakefulness. EEG/EMG studies also reveal incomplete REM sleep atonia with abnormal myoclonic activity during this sleep stage. These results suggest that endogenous orexinergic activity should be appropriately regulated for normal maintenance of sleep states. Orexinergic transmission should be activated during wakefulness, while it should be inactivated or decreased during sleep state to maintain appropriate vigilance states.

KW - Hypocretin

KW - Orexin

KW - Overexpression

KW - Sleep

KW - Transgenic

KW - Wakefulness

UR - http://www.scopus.com/inward/record.url?scp=79951673017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951673017&partnerID=8YFLogxK

U2 - 10.1007/s12031-010-9437-7

DO - 10.1007/s12031-010-9437-7

M3 - Article

C2 - 20711757

AN - SCOPUS:79951673017

VL - 43

SP - 155

EP - 161

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 2

ER -